AstraZeneca, breast cancer
AstraZeneca drug fails to extend lives of breast cancer patients significantly
A new AstraZeneca drug has failed to extend significantly the lives of breast cancer patients in a blow to the company’s ambitions to hit an $80bn revenue target by 2030. Datopotamab deruxtecan (Dato-DXd) is a new form of cancer treatment,
Ryan Reynolds surprises boy battling cancer
About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...
Kate, the Princess of Wales, made her first public appearance Sunday since she announced she had completed chemotherapy and ...
4don MSN
The latest Cancer Progress Report from the American Association for Cancer Research also found a 24% decline in the overall ...
Cancer deaths are down in the U.S., but the disease is taking hold in younger populations, likely fueled by obesity, alcohol ...
A new report from the American Association for Cancer Research emphasizes a cancer risk that its authors say is being ...
The report, which calls on Congress to increase funding, highlights some of the major advances made in cancer care as well areas where more research and attention are needed.
Scientists studying cancer in the lab often take biopsies of patients’ cancer cells to clone them. The process is ...
Patients receiving chemotherapy in Lincolnshire can now have additional treatment to help reduce their hair loss. Many cancer ...
The Navy says its highest-ranking military officer has been successfully treated for early-stage breast cancer. The service ...
Kate and Prince William were seen Sunday attending church with King Charles II and Queen Camilla near their royal Balmoral ...
Amivantamab plus chemo is now indicated in locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback